FDA Needs Alternative To Labels To Change Behavior, IoM Safety Cmte. Says

FDA needs to develop a more proactive tool to change prescribing behavior rather than relying on labeling, panelists said at the Jan. 17 meeting of the Institute of Medicine's Committee on the Assessment of the U.S. Drug Safety System